Nathan R. Rose

5.6k citations
32 papers · 4.1k indexed · 1 hit paper · h-index 25
Topics
Epigenetics and DNA Methylation (23 papers)Histone Deacetylase Inhibitors Research (13 papers)Cancer-related gene regulation (13 papers)

In The Last Decade

Nathan R. Rose

32 papers receiving 4.0k citations

Hit Papers

The oncometabolite 2‐hydroxyglutarate inhibits histone ly...20112026201620212011250500750

Peers

Nathan R. Rose
Comparison fields: 5 of 112
  • Molecular Biology 3.5k
  • Cancer Research 863
  • Genetics 378
  • Oncology 254
  • Genetics 237
Replace Christoph Loenarz with:
Christoph Loenarz United Kingdom
Oliver N. F. King United Kingdom
Jinyun Liu United States
Mathias Montenarh Germany
Yu-ichi Tsukada Japan
Takako Furukawa Japan
Xinlin Du United States
Cathrine Broberg Vågbø Norway
M. Christiane Brahimi-Horn France
Tsuyoshi Ikura Japan
Nathan R. Rose relative to Christoph Loenarz United Kingdom Christoph Loenarz's profile →
Citations per field
00.5×2.7×
Christoph Loenarz · 1×
Citations per year

Countries citing papers authored by Nathan R. Rose

Since Specialization
Citations

This map shows the geographic impact of Nathan R. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan R. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan R. Rose more than expected).

Fields of papers citing papers by Nathan R. Rose

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan R. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan R. Rose. The network helps show where Nathan R. Rose may publish in the future.

Co-authorship network of co-authors of Nathan R. Rose

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan R. Rose. A scholar is included among the top collaborators of Nathan R. Rose based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan R. Rose. Nathan R. Rose is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 10
3 266
4 4
5 34
6
Discovery of ML324, a JMJD2 demethylase inhibitor with demonstrated antiviral activity
25
7 55
8 61
9 140
10
The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylasesbreakdown →
762
11 304
12 48
13 51
14 53
15 173
16 28
17 76
18 72
19 136
20 263

About Nathan R. Rose

Nathan R. Rose is a scholar working on Molecular Biology, Cancer Research and Biochemistry, having authored 32 papers that have together received 4.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (23 papers), Histone Deacetylase Inhibitors Research (13 papers) and Cancer-related gene regulation (13 papers). The work is most often cited by research in Cancer Research (863 citations), Molecular Biology (3.5k citations) and Genetics (237 citations). Nathan R. Rose has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include Robert J. Klose, Christopher J. Schofield, M.A. McDonough, Oliver N. F. King, Akane Kawamura, Neil P. Blackledge, Udo Oppermann, Stanley S. Ng, Esther C. Y. Woon and Peter J. Ratcliffe. Their work appears in journals such as Nature, Chemical Society Reviews and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026